BOVIE MEDICAL CORPORATION TO RELEASE SECOND QUARTER 2017 FINANCIAL RESULTS ON AUGUST 2, 2017
CLEARWATER, FL — July 10, 2017 – Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial results for the second quarter of 2017 will be released after the market closes on Wednesday, August 2.
Management will host a conference call at 4:30 p.m. Eastern Time on August 2nd to discuss the results of the quarter and host a question and answer session. To listen to the call by phone, interested parties may dial 844-507-6493 (or 647-253-8641 for international callers) and provide access code 51614469. Participants should ask for the Bovie Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and at: https://event.on24.com/wcc/r/1462925/FFFEFCC2DEDC4963062FDE9C9430032A.
A telephonic replay will be available approximately two hours after the end of the call through August 16, 2017. The replay can be accessed by dialing 800-585-8367 for U.S. callers or 416-621-4642 for International callers and using the replay access code: 51614469. The webcast will be archived on the Investor Relations section of the Company’s website.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, IDS™, ICON™ and DERM™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation at www.boviemed.com.
Mike Piccinino, CFA